Correlation Between Viridian Therapeutics and Humana
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Humana at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Humana into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Humana Inc, you can compare the effects of market volatilities on Viridian Therapeutics and Humana and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Humana. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Humana.
Diversification Opportunities for Viridian Therapeutics and Humana
-0.8 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Viridian and Humana is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Humana Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Humana Inc and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Humana. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Humana Inc has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Humana go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Humana
Assuming the 90 days trading horizon Viridian Therapeutics is expected to under-perform the Humana. In addition to that, Viridian Therapeutics is 1.29 times more volatile than Humana Inc. It trades about -0.01 of its total potential returns per unit of risk. Humana Inc is currently generating about 0.19 per unit of volatility. If you would invest 26,473 in Humana Inc on August 31, 2024 and sell it today you would earn a total of 3,199 from holding Humana Inc or generate 12.08% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. Humana Inc
Performance |
| Timeline |
| Viridian Therapeutics |
| Humana Inc |
Viridian Therapeutics and Humana Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and Humana
The main advantage of trading using opposite Viridian Therapeutics and Humana positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Humana can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humana will offset losses from the drop in Humana's long position.| Viridian Therapeutics vs. HCA Healthcare | Viridian Therapeutics vs. Optima Health plc | Viridian Therapeutics vs. BW Offshore | Viridian Therapeutics vs. Naturhouse Health SA |
| Humana vs. Young Cos Brewery | Humana vs. PureTech Health plc | Humana vs. MTI Wireless Edge | Humana vs. Ashtead Technology Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |